Investing.com - Eli Lilly (NYSE:LLY) reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Eli Lilly announced earnings per share of $2.49 on revenue of $8B. Analysts polled by Investing.com anticipated EPS of $2.45 on revenue of $7.69B.
Eli Lilly shares are down 9% from the beginning of the year, still down 11.65% from its 52 week high of $283.90 set on December 16, 2021. They are under-performing the S&P 500 which is down 3.71% from the start of the year.
Eli Lilly follows other major Healthcare sector earnings this month
Eli Lilly's report follows an earnings beat by J&J on January 25, who reported EPS of $2.13 on revenue of $24.8B, compared to forecasts EPS of $2.12 on revenue of $25.28B.
UnitedHealth had beat expectations on January 19 with fourth quarter EPS of $4.48 on revenue of $73.74B, compared to forecast for EPS of $4.3 on revenue of $72.98B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar